Leptin signaling and cancer chemoresistance: Perspectives

por Candelaria, Pierre V, Rampoldi, Antonio, Harbuzariu, Adriana, Gonzalez-Perez, Ruben R
Publicado 2017

A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma

por Candelaria, Pierre V., Nava, Miguel, Daniels-Wells, Tracy R., Penichet, Manuel L.
Publicado 2023

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

por Candelaria, Pierre V., Leoh, Lai Sum, Penichet, Manuel L., Daniels-Wells, Tracy R.
Publicado 2021

Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation

por Daley-Brown, Danielle, Oprea-Iles, Gabriela, Vann, Kiara T., Lanier, Viola, Lee, Regina, Candelaria, Pierre V., Quarshie, Alexander, Pattillo, Roland, Gonzalez-Perez, Ruben Rene
Publicado 2017

Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma

por Daniels-Wells, Tracy R., Candelaria, Pierre V., Kranz, Emiko, Wen, Jing, Wang, Lan, Kamata, Masakazu, Almagro, Juan C., Martínez-Maza, Otoniel, Penichet, Manuel L.
Publicado 2023

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

por Hickerson, Brady T., Daniels-Wells, Tracy R., Payes, Cristian, Clark, Lars E., Candelaria, Pierre V., Bailey, Kevin W., Sefing, Eric J., Zink, Samantha, Ziegenbein, James, Abraham, Jonathan, Helguera, Gustavo, Penichet, Manuel L., Gowen, Brian B.
Publicado 2022